Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment

by Junmei Shang, Shurong Ma, Caixia Zang, Xiuqi Bao, Yan Wang, Dan Zhang
Published 2021-05-01

Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis

by Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang
Published 2021-09-01

Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models

by Hanyu Yang, Lu Wang, Caixia Zang, Yue Wang, Junmei Shang, Zihong Zhang, Hui Liu, Xiuqi Bao, Xiaoliang Wang, Dan Zhang
Published 2020-02-01

Squamosamide Derivative FLZ Diminishes Aberrant Mitochondrial Fission by Inhibiting Dynamin-Related Protein 1

by Hanyu Yang, Lu Wang, Caixia Zang, Xu Yang, Xiuqi Bao, Junmei Shang, Zihong Zhang, Hui Liu, Cheng Ju, Fangyuan Li, Fangyu Yuan, Dan Zhang
Published 2021-03-01

CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis

by Lu Wang, Hanyu Yang, Caixia Zang, Yi Dong, Junmei Shang, Jiajing Chen, Yue Wang, Hui Liu, Zihong Zhang, Heng Xu, Xiuqi Bao, Dan Zhang
Published 2020-02-01